Aksam Abdelkhalik | Biomaterials | Innovative Research Award

Published on by Material Scientist

Innovative Research Award

Aksam Abdelkhalik
Affiliation National Institute of Standards
Country Egypt
Scopus ID 57188844653
Documents 28
Citations 643
h-index 13
Subject Area Biomaterials
Event International Material Scientist Awards
ORCID 0000-0002-0308-1745

Aksam Abdelkhalik is a researcher affiliated with the National Institute of Standards in Egypt whose indexed scholarly record is associated with the field of biomaterials. The available Scopus information records 28 documents, 643 citations, and an h-index of 13, providing a bibliometric overview of the researcher’s publication and citation activity. The Innovative Research Award recognizes research contributions that demonstrate originality, methodological value, and potential significance within materials science and related disciplines. [1]

Abstract

Aksam Abdelkhalik is a biomaterials researcher associated with the National Institute of Standards in Egypt. According to the supplied Scopus record, the researcher has 28 indexed documents, 643 citations, and an h-index of 13. ย These bibliometric indicators provide evidence of sustained scholarly activity and citation recognition within the indexed research literature. [1]

Keywords

Aksam Abdelkhalik; Innovative Research Award; biomaterials; materials science; National Institute of Standards; Egypt; Scopus; scholarly publications; citation impact; research innovation; biomaterials research; scientific research; academic recognition; International Material Scientist Awards.[2]

Introduction

Biomaterials research focuses on the development, characterization, and application of materials designed to interact with biological systems for biomedical and healthcare applications. It integrates materials science, chemistry, biology, physics, engineering, and nanotechnology to advance areas such as tissue engineering, drug delivery, medical implants, biosensors, and regenerative medicine.[1]

Research Profile

Aksam Abdelkhalik is affiliated with the National Institute of Standards in Egypt and is identified within the supplied academic information with a research focus in biomaterials. The profile is supported by researcher identifiers and a Scopus Author ID, helping distinguish the researcherโ€™s scholarly identity and indexed publication record from other researchers with similar names.[4]

Research Contributions

The supplied information places Aksam Abdelkhalik’s research within biomaterials, an area concerned with materials and interfaces relevant to biological and biomedical environments. The available record does not provide sufficient publication-level information to attribute specific materials, experimental methods, applications, or individual discoveries to the researcher without risk of introducing unsupported claims.[5]

Publications

The supplied information confirms 28 documents associated with Aksam Abdelkhalik in the Scopus record. Individual publication titles, journals, publication dates, co-authors, and identifiers were not provided in the source data for this profile. Consequently, specific publications are not listed here to avoid attributing bibliographic information that has not been independently supplied.[2]

Research Impact

Citation indicators are quantitative measures and do not independently establish the scientific quality or societal significance of research. A balanced assessment should consider publication quality, originality, research methodology, contribution to the field, collaboration, reproducibility, and the relevance of the work to ongoing scientific challenges.[3]

Award Suitability

The Innovative Research Award is presented within the context of the International Material Scientist Awards. Aksam Abdelkhalik’s affiliation with the National Institute of Standards, research-area classification in biomaterials, and documented indexed research activity provide relevant evidence for consideration under an award category focused on innovative research.[4]

Conclusion

The documented research profile is relevant to consideration for the Innovative Research Award associated with the International Material Scientist Awards. A complete evaluation should combine bibliometric evidence with detailed assessment of the researcher’s individual publications, originality, scientific methodology, and contribution to biomaterials and materials science.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Aksam Abdelkhalik, Author ID 57188844653. Scopus.
    http://scopus.com/authid/detail.uri?authorId=57188844653
  2. ORCID. (n.d.). ORCID record: Aksam Abdelkhalik, ORCID iD 0000-0002-0308-1745. ORCID.
    https://orcid.org/0000-0002-0308-1745
  3. International Material Scientist Awards. (n.d.).
    https://materialscientists.com
  4. Yang, Y.-T., Li, Y., Hu, Y., Abdelkhalik, A., Yu, B., & Wang, X. (2026). Phosphophenanthrene-containing piperazine cured epoxy resins with simultaneously enhanced flame retardancy, mechanical performance, and dielectric properties. Progress in Organic Coatings, 219, 110318. https://doi.org/10.1016/j.porgcoat.2026.110318
  5. Yang, Y.-T., Shi, H.-J., Li, Y., Hu, Y., Abdelkhalik, A., Yu, B., & Wang, X. (2026). A novel phosphorusโ€“nitrogen-containing hardener toward anti-flammable, smoke-suppressed and low-dielectric epoxy thermosets. Journal of Materials Chemistry A, 14(35), 23476โ€“23487
    http://doi.org/10.1039/D5TA10487D

Aristos Aristidou | Biomaterials | Biomaterials Excellence

Published on by Material Scientist

Biomaterials Excellence

Aristos Aristidou
Name Aristos Aristidou
Affiliation Texas A&M University
Country United States
Scopus ID 6602073871
Documents 27
Citations 1,547
h-index 20
Subject Area Biomaterials
Event International Material Scientist Awards
ORCID 0000-0002-4873-3639

Aristos Aristidou is a researcher associated with Texas A&M University (TAMU), United States. His research profile highlights biomaterials as a principal subject area, with broader research interests spanning biochemical engineering, metabolic engineering, biomanufacturing, and materials-related applications. Publicly available research-profile information further associates his work with interdisciplinary research at the intersection of engineering, biotechnology, and advanced materials. [1]

Abstract

This academic recognition profile presents the research record of Aristos Aristidou, affiliated with Texas A&M University (TAMU), United States, in the context of biomaterials and related interdisciplinary research. The supplied Scopus profile information identifies 27 documents, 1,547 citations, and an h-index of 20. These bibliometric indicators provide a quantitative overview of indexed scholarly output and citation activity. [1]

Keywords

Aristos Aristidou; Biomaterials; Texas A&M University; TAMU; Materials Science; Biomedical Materials; Biochemical Engineering; Metabolic Engineering; Biomanufacturing; Bioengineering; Advanced Biomaterials; Sustainable Biomanufacturing; Materials Engineering; Biotechnology; Scopus; Research Impact; h-index; Academic Excellence; International Material Scientist Awards. [2]

Introduction

Biomaterials research encompasses the design, development, characterization, and application of materials that interact with biological systems. Its scope intersects materials science, biotechnology, chemical engineering, biomedical engineering, and related disciplines. Within this broader research landscape, interdisciplinary approaches can contribute to the development of functional materials and scalable biological or biochemical processes. [1]

Research Profile

The supplied profile records 27 documents, 1,547 citations, and an h-index of 20 for Aristos Aristidou. These values represent the bibliometric snapshot supplied for this article and may change as Scopus updates indexed records and citation data. Scopus supports author identification through author names, affiliations, and Scopus Author Identifiers. [3]

Research Contributions

The research profile associated with Aristos Aristidou indicates an interdisciplinary orientation involving biochemical engineering, metabolic engineering, bioprocess development, and biomanufacturing. Publicly available research-profile information associates his work with areas including metabolic engineering, fermentation, sustainable biomanufacturing, and engineering applications, illustrating the connection between biological production systems and engineering-oriented research. [4]

Publications

The supplied Scopus record reports 27 indexed documents for Aristos Aristidou. A documented publication associated with his research is Metabolic engineering applications to renewable resource utilization, published in Current Opinion in Biotechnology. Publication counts can differ among databases because of indexing coverage and document types. [3]

Research Impact

The reported citation count and h-index provide quantitative indicators of scholarly visibility. For a balanced assessment, citation indicators should be considered together with publication quality, research leadership, collaboration, technological relevance, intellectual contributions, and evidence of influence within the relevant scientific community. Author identifiers such as Scopus Author IDs and ORCID can also assist with author identification and record disambiguation. [1]

Award Suitability

The reported Scopus indicatorsโ€”27 documents, 1,547 citations, and an h-index of 20โ€”provide quantitative evidence that may support an award evaluation, but they should not be treated as the sole basis for selection. A comprehensive assessment can additionally consider originality, publication quality, research relevance, technological or translational significance, collaboration, and documented contributions to biomaterials and related scientific fields. [2]

Conclusion

Taken together, the supplied bibliometric information provides a structured basis for considering the researcher’s suitability within a material-science recognition framework. Final award evaluation should incorporate verified publication records, research quality, originality, field relevance, and other documented scholarly contributions in addition to bibliometric indicators. [4]

References

  1. Elsevier. (n.d.). Scopus author search and author identification. Scopus Support Center.
    https://www.scopus.com/pages/authors/6602073871
  2. International Material Scientist Awards. (n.d.).
    https://materialscientists.com
  3. Aristidou, A. A. (2000). Metabolic engineering applications to renewable resource utilization. Current Opinion in Biotechnology, 11(2), 187โ€“198.
    https://doi.org/10.1016/S0958-1669(00)00085-9
  4. Aristidou, A. A. (n.d.). Aristos Aristidou. Texas A&M University, Department of Chemical Engineering.
    https://orcid.org/0000-0002-4873-3639

Bindiya Barsola | Biomaterials | Innovative Research Award

Published on by Material Scientist

Innovative Research Award

Bindiya Barsola
Affiliation Arni University
Country India
Scopus ID 57810558400
Documents 13
Citations 131
h-index 6
Subject Area Biomaterials
Event International Material Scientist Awards

Bindiya Barsola is a researcher affiliated with Arni University, India, whose supplied research profile is associated with the subject area of biomaterials. The available Scopus information identifies 13 documents, 131 citations, and an h-index of 6. These bibliometric indicators provide a quantitative overview of the research output and scholarly visibility represented in the supplied profile. The Innovative Research Award recognition profile places Barsola’s research record within the broader context of materials science and biomaterials research.[1]

Abstract

This academic recognition profile presents the research record of Bindiya Barsola, affiliated with Arni University, India, in the field of biomaterials. According to the supplied Scopus profile information, Barsola has 13 indexed documents, 131 citations, and an h-index of 6 These indicators suggest an established body of indexed scholarly output with measurable citation visibility. [1]

Keywords

Biomaterials; Materials Science; Innovative Research; Arni University; Scopus; Bibliometrics; Research Impact; Citation Analysis; Academic Recognition; International Material Scientist Awards; Biomaterials Research; Scientific Innovation; Materials Engineering; Research Productivity; Academic Achievement; Scientific Recognition. [2]

Introduction

Biomaterials research encompasses the investigation, design, characterization, and application of materials intended to interact with biological systems. The field intersects materials science, biology, and related disciplines, and contributes to the development of materials for biomedical and technological applications.Within this interdisciplinary environment and h-index are commonly used to describe aspects of scholarly output and citation visibility. [1]

Research Profile

Bindiya Barsola is a researcher affiliated with Arni University, India, whose supplied academic profile identifies biomaterials as the principal subject area. Her research profile is situated within the broader field of materials science, with biomaterials representing an interdisciplinary area connecting materials engineering, biological sciences, and biomedical applications. [3]

Research Contributions

The supplied subject classification places Barsola’s research within biomaterials, a field concerned with the relationship between material properties and biological environments. Research in this area may involve material synthesis, surface modification, characterization, biocompatibility, mechanical performance, degradation, and application-oriented evaluation.[4]

Publications

The supplied Scopus record reports 13 documents associated with Bindiya Barsola. Because individual publication titles, journals, publication years,ย  this profile does not attribute specific papers or research findings to the researcher without additional bibliographic verification.For a complete publication analysis, individual records can be evaluated according to publication venue,ย  collaboration patterns, and persistent identifiers.[1]

Research Impact

The supplied profile reports 131 citations across 13 Scopus documents, corresponding to an average of approximately 10.1 citations per indexed document when calculated from the provided aggregate figures. This value is descriptive rather than a measure of research quality, because citation patterns vary substantially among disciplines, under the supplied Scopus record, at least six indexed publications have received at least six citations each. [2]

Award Suitability

Based on the information provided, the profile demonstrates several characteristics relevant to an academic recognition assessment: a defined research area, an identifiable institutional affiliation, indexed scholarly documents, citation activity, and a measurable h-index. However, a complete award assessment should also consider the originality of research and the specific eligibility and evaluation criteria of the award.[3]

Conclusion

In the context of the Innovative Research Award under the International Material Scientist Awards, the supplied profile demonstrates relevance to materials science through its biomaterials focus and provides measurable bibliometric evidence of scholarly activity. A definitive assessment of research excellence, however, should incorporate publication-level evidence and the formal criteria established by the awarding organization.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Bindiya Barsola, Author ID 57810558400. Scopus.
    https://www.scopus.com/pages/authors/57810558400
  2. International Material Scientist Awards. (n.d.).
    https://materialscientists.com
  3. Jha, A., Barsola, B., Pathania, D., Sonu, Raizada, P., Thakur, P., Singh, P., Rustagi, S., Khosla, A., & Chaudhary, V. (2024). Nano-biogenic heavy metals adsorptive remediation for enhanced soil health and sustainable agricultural production. Environmental Research, 252, 118926.
    https://doi.org/10.1016/j.envres.2024.118926
  4. Barsola, B., & Kumari, P. (2022). Green synthesis of nano-propolis and nanoparticles (Se and Ag) from ethanolic extract of propolis, their biochemical characterization: A review. Green Processing and Synthesis, 11(1), 659โ€“673.
    https://doi.org/10.1515/gps-2022-0059

Dr. Min-Kyu Park | Biomaterials | Research Excellence Award

Published on by Material Scientist

Dr. Min-Kyu Park | Biomaterials | Research Excellence Award

Kyungpook National University | Republic of Korea

Dr. Min-Kyu Park is a Research Professor at Kyungpook National University recognized for his significant contributions to biomaterials, microbial biotechnology, and genomic research. His work focuses on exploring the functional roles of microorganisms and developing innovative bio-based technologies that support sustainable agriculture, environmental management, and biomedical applications. Through the integration of next-generation sequencing, microbiome analysis, and bioinformatics, he investigates microbial diversity and metabolic pathways to identify beneficial microorganisms with industrial and agricultural potential. Dr. Park has actively led and collaborated on numerous national and international research initiatives, advancing the understanding of plant growthโ€“promoting bacteria, enzyme-producing microbial strains, and environmentally friendly biological solutions. His research has resulted in a strong portfolio of peer-reviewed publications and several patented microbial technologies that have been successfully translated into commercial products such as biofertilizers, feed additives, and biological pest-control agents. By bridging fundamental microbiological science with biomaterials development and biotechnology innovation, he contributes to sustainable resource management and next-generation biological product development. His interdisciplinary research continues to support advances in microbial engineering, environmental sustainability, and applied biomaterial technologies.

Citation Metrics (Scopus)

200
150
100
50
0

Citations
139

Documents
18

h-index
6

Citations

Documents

h-index


View Scopus Profile
 ย ย  ย ย View Google Scholar Profile

Featured Publications

Prof. Dr. Hwa-Jin Park | Biomaterials | Research Excellence Award

Published on by Material Scientist

Prof. Dr. Hwa-Jin Park | Biomaterials | Research Excellence Award

Inje University | Republic of Korea

Prof. Dr. Hwa-Jin Park is a distinguished Professor Emeritus at Inje University, Korea, widely recognized for his significant contributions to biomaterials, platelet biology, and thrombosis research. His academic work focuses on the molecular mechanisms regulating platelet activation and thrombotic disease, particularly TXAโ‚‚-dependent signaling pathways, phosphorylation-mediated regulation, and integrin ฮฑIIbฮฒโ‚ƒ activation. Through integrated biochemical, cellular, and functional research approaches, he has advanced the understanding of bioactive natural compounds such as cordycepin and ginseng-derived saponins, demonstrating their potential as antiplatelet and circulation-enhancing agents. His research bridges fundamental biomedical science with translational applications aimed at improving prevention and treatment strategies for cardiovascular and thrombotic disorders. He has led major research initiatives and served as Director of the Biohealth Materials Research Center at Inje University while also contributing internationally as an invited professor at Kyoto University. With an extensive portfolio of peer-reviewed scientific publications, strong citation impact, and several patented innovations related to antiplatelet compounds and biomedical applications, Professor Park has played a pivotal role in advancing biomaterials and molecular biomedical research. His work continues to influence therapeutic development, functional biomaterials research, and the broader field of cardiovascular health science.

Citation Metrics (Scopus)

2500
2000
1000
500
0

Citations
1918

Documents
29

h-index
27

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Prof. Dr Jiang Chao | Biomaterials | Best Researcher Award

Published on by Material Scientist

Prof. Dr Jiang Chao | Biomaterials | Best Researcher Award

Dr. Jiang Chao ๐ŸŽ“๐Ÿง  is a leading neurologist and researcher at the Second Affiliated Hospital of Xiโ€™an Medical University, specializing in integrative medicine, cerebrovascular diseases, and neuro-AI. With a Ph.D. from Shanghai University of Traditional Chinese Medicine, he has published over 90 scientific papers ๐Ÿ“š, including 33 SCI-indexed articles ๐ŸŒ. His innovations span AI-driven diagnostics, ALS interventions, and electroacupuncture therapies โš™๏ธ๐Ÿงช. Holder of 8 patents and author of 6 medical books, he also plays pivotal roles in 40+ medical associations ๐Ÿ…. Dr. Jiang is shaping the future of clinical neuroscience and integrative neurology worldwide. ๐ŸŒ๐Ÿ’ก

Prof. Dr jiang chao, The Second Affiliated Hospital of Xi ‘an Medical University, China

Profile

ORCID

๐ŸŽ“ Educationย 

Dr. Jiang Chao earned his Ph.D. in Integrative Medicine (Neurology) from Shanghai University of Traditional Chinese Medicine in 2014. Currently, he serves as Director of Neurology at the Second Affiliated Hospital of Xiโ€™an Medical University and Adjunct Professor at Northwestern University School of Medicine, Xiโ€™an ๐Ÿ‡จ๐Ÿ‡ณ. He is also the Honorary Director of the Tuberculosis Meningitis Department at Shaanxi Provinceโ€™s Fifth Hospital ๐Ÿฅ. His academic journey is enriched by over 70 high-impact publications ๐Ÿ“š and a commitment to advancing medical education, with expertise spanning AI in neurology, stroke management, and clinical innovation ๐Ÿ”ฌ๐Ÿ’ก.

๐Ÿฅ Experience

Dr. Chao Jiang ๐Ÿง ๐ŸŽ“ is currently the Director of Neurology at the Second Affiliated Hospital of Xiโ€™an Medical University (2018โ€“present) ๐Ÿฅ, where he leads advancements in cerebrovascular and neurological care. He also serves as Honorary Director (Tuberculosis Meningitis Specialist) at the Fifth Hospital of Shaanxi Province ๐Ÿงฌ and Adjunct Professor at Northwestern University School of Medicine, Xiโ€™an ๐ŸŽ“. Previously, he completed a Postdoctoral Fellowship at Longhua Hospital, Shanghai University of Traditional Chinese Medicine (2019โ€“2022), focusing on emergency neurology ๐Ÿšจ. His multidisciplinary experience bridges clinical neurology, AI applications, and integrative therapies, making him a pioneer in translational brain health research. ๐Ÿ’ก๐Ÿงช

๐Ÿงฌ Contributions

Dr. Jiang Chaoโ€™s research investigates the therapeutic potential of early electroacupuncture (EA) on amyotrophic lateral sclerosis (ALS) by targeting the HMGB1/TLR4 signaling pathway ๐Ÿ”ฌ๐Ÿงฌ. The study aims to assess how EA modulates related protein expression and preserves oligodendrocyte integrity, ultimately improving motor function in ALS-affected mice ๐Ÿฆด๐Ÿƒโ€โ™‚๏ธ. This innovative work integrates molecular neurobiology with traditional Chinese medicine, offering promising insights into non-pharmacological intervention for neurodegeneration. Dr. Jiangโ€™s findings contribute significantly to neuroinflammation regulation, opening new doors for ALS treatment using integrative approaches. ๐ŸŒฟ๐Ÿงช๐Ÿ’ก

๐Ÿ”ฌ Research Focus

Prof. Dr. Jiang Chaoโ€™s research lies at the intersection of neurology and integrated traditional Chinese and Western medicine ๐Ÿงฌ๐ŸŒฟ. His work explores innovative, evidence-based approaches to treating neurological disorders such as stroke, Parkinsonโ€™s disease, and Alzheimerโ€™s through synergistic therapies combining modern neuroscience ๐Ÿง  and classical Chinese herbal and acupuncture practices ๐Ÿชท๐Ÿ’‰. He aims to enhance clinical outcomes, reduce side effects, and personalize treatment through integrative protocols. His research contributes to bridging the gap between ancient healing wisdom and cutting-edge biomedical science, promoting a holistic and effective model for neurological care and brain health ๐Ÿฉบ๐ŸŒ.

๐Ÿ“š Publication

[Retracted] Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma
Authors: Xu Chao, Wei Zhang, Jieqiong Wu, Xuesong Feng, Hailong Shi, Luyan Zhao, Haiyu Shen, Chao Jiang, Qian Wang
Journal: BioMed Research International (2021)

Effects of Electroacupuncture on the HMGB1/TLR4 Pathway and Oligodendrocytes in the Cerebral Cortex of Mice with Amyotrophic Lateral Sclerosis
Authors: Jiawei Zeng, Weijia Zhao, Junyang Liu, Shanshan Liu, Le Li, Weixing Feng, Yingqian Zhao, Qiang Wang, Chao Jiang
Journal: Journal of Acupuncture and Tuina Science (2025)

Prof. Dr Hein Van Poppel | Biomaterials | Best Researcher Award

Published on by Material Scientist

Prof. Dr Hein Van Poppel | Biomaterials | Best Researcher Award

Prof. Dr. Hein Van Poppel ๐Ÿ‡ง๐Ÿ‡ช is an internationally renowned urologist and oncologist ๐Ÿ‘จโ€โš•๏ธ๐Ÿ”ฌ with over four decades of experience in prostate, bladder, and kidney cancer surgery ๐ŸŽฏ๐Ÿงฌ. As Full Professor at KU Leuven and former Director of Education at the European School of Urology ๐Ÿ“˜๐Ÿฅ, he has mentored thousands and performed 3,000+ prostatectomies. Author of over 500 scientific publications ๐Ÿ“šโœ๏ธ and recipient of multiple lifetime achievement awards ๐Ÿ†, he has revolutionized urologic care with innovations like the โ€œNโ€ pouch. His commitment to research, education, and patient advocacy makes him a global leader in medical science ๐ŸŒ๐Ÿ’ก.

Prof. Dr Hein Van Poppel, EAU and KU Leuven, Belgium

Profile

ORCID

๐ŸŽ“ Educationย 

Prof. Dr. Hein Van Poppel ๐ŸŽ“ is a leading figure in urology, earning his MD in General Surgery (1980) and Urology (1983), followed by a Ph.D. in Medical Sciences in 1988 ๐Ÿง ๐Ÿ“˜. He completed postgraduate training in major European centers including London, Barcelona, Copenhagen, Mainz, and Rotterdam ๐ŸŒ๐Ÿ”ฌ. In 1992, he became a Fellow of the European Board of Urology (FEBU) ๐Ÿ…. Appointed Full Professor at KU Leuven in 1993 and Department Chair by 2002, his academic path laid the foundation for a distinguished global career in urologic oncology and medical education ๐Ÿงช๐Ÿฅ.

๐Ÿ‘จโ€โš•๏ธ Experienceย 

Prof. Dr. Hein Van Poppel is a world-renowned urologist ๐Ÿ‘จโ€โš•๏ธ with over 40 years of experience in uro-oncology, academic leadership, and surgical innovation ๐Ÿ”ฌโœ‚๏ธ. Former Chair of Urology at KU Leuven ๐Ÿฅ, he pioneered techniques like the โ€œNโ€ pouch and prepubic urethrectomy. He served as Adjunct Secretary General of the EAU and Director of the European School of Urology ๐Ÿ“˜๐Ÿ‡ช๐Ÿ‡บ. With 3,000+ radical prostatectomies, 35+ doctoral mentorships ๐ŸŽ“, and 1,000+ global lectures ๐ŸŒ๐ŸŽค, he has significantly shaped prostate cancer care, surgical education, and health policy through EU initiatives like PRAISE-U ๐Ÿง ๐Ÿ›๏ธ.

๐Ÿ† Awards, Leadership & Impactย 

Prof. Van Poppel has received prestigious awards including the Folke Edsmyr Award (๐Ÿ‡ธ๐Ÿ‡ช1999), Pieter De Mulder Award (๐Ÿ‡ซ๐Ÿ‡ท2015), Francisco Diaz Medal (๐Ÿ‡ช๐Ÿ‡ธ2015), SIU Distinguished Career Award (๐Ÿ‡ฆ๐Ÿ‡ท2016), and the Frans Debruyne Lifetime Achievement Award (2021) ๐Ÿ…. In 2024โ€“2025, he earned the Klaus-Meier Award, Laurent Boccon-Gibod Award, and the Wil de Jongh Medal ๐Ÿ†. As EAU Adjunct Secretary General, he established the Patient Office ๐Ÿง‘โ€โš•๏ธ๐Ÿ—ฃ๏ธ, Policy Office ๐Ÿ›๏ธ, and now coordinates PRAISE-U, an EU-funded initiative shaping the future of prostate cancer screening in Europe ๐Ÿ‡ช๐Ÿ‡บ๐Ÿ“Š. His leadership bridges research, advocacy, and public health innovation ๐ŸŒ๐Ÿ”ฌ.

๐Ÿงฌ Research Focusย 

Prof. Van Poppelโ€™s research focuses on prostate, bladder, kidney, and testicular cancers ๐Ÿ”ฌ๐Ÿงฌ, with a strong emphasis on early detection, screening policies, and surgical oncology. He has led major studies on PSA testing, PRAISE-U early detection programs, and neoadjuvant therapies for high-risk prostate cancer ๐Ÿงช๐Ÿ’‰. His work addresses public health impact, patient outcomes, and inequalities in urological cancer care across Europe ๐ŸŒ๐Ÿฅ. With groundbreaking contributions in clinical trials, surgical techniques, and policy advocacy ๐Ÿ“ˆ๐Ÿ“œ, his research bridges clinical excellence and health equityโ€”paving the way for smarter, earlier, and more effective cancer interventions ๐Ÿš€๐ŸŽฏ.

๐Ÿ“˜ Publications

Title: SIU-ICUD: Screening and Early Detection of Prostate Cancer
Contributors: Ola Bratt, Mohamed Jalloh, Anwar R. Padhani, Paul F. Pinsky, Hein Van Poppel, Weranja Ranasinghe, Kamran Zargar-Shoshtari, Kai Zhang, Anssi Auvinen
Journal: Sociรฉtรฉ Internationale dโ€™Urologie Journal (2025)

Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey
Contributors: Katharina Beyer, Renรฉe C. A. Leenen, Lionne D. F. Venderbos, Jozien Helleman, Sebastiaan Remmers, Vera Vasilyeva, Juan Gรณmez Rivas, Erik Briers, Thomas Frese, Josep Vilaseca et al.
Journal: Journal of Personalized Medicine (2024)

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium
Contributors: Katharina Beyer, Renรฉe Leenen, Lionne Venderbos, Jozien Helleman, Frederique Denijs, Wichor Bramer, Vera Vasilyeva, Erik Briers, Juan Gรณmez Rivas, Renata Chloupkova et al.
Journal: Journal of Personalized Medicine (2024)

Navigating Through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs
Contributors: Juan Gรณmez Rivas, Renรฉe C. A. Leenen, Lionne Venderbos, Jozien Helleman, Irene de la Parra, Vera Vasilyeva, Moreno-Sierra J., Partha Basu, Arunah Chandran, Roderick C. N. van den Bergh et al.
Journal: Journal of Personalized Medicine (2023)

European Cancer Organisation’s Inequalities Network: Putting Cancer Inequalities on the European Policy Map
Contributors: Hendrik Van Poppel, Nicolรฒ M. L. Battisti, Mark Lawler, Teodora Kolarova, Jacqueline Daly, Katie Rizvi, Robert Greene, Guy Buyens, Kathy Oliver, Richard Price et al.
Journal: JCO Global Oncology (2022)

Serum PSA-Based Early Detection of Prostate Cancer in Europe and Globally: Past, Present and Future
Contributors: Hendrik Van Poppel, Tit Albreht, Partha Basu, Renรฉe Hogenhout, Sarah Collen, Monique Roobol
Journal: Nature Reviews Urology (2022)

Dr Eun-Gyung Cho | Biomaterials | Best Researcher Award

Published on by Material Scientist

Dr Eun-Gyung Cho | Biomaterials | Best Researcher Award

Dr. Eun-Gyung Cho is a leading biomedical scientist specializing in extracellular vesicles (EVs), skin biology, and stem cell applications. She currently holds multiple leadership positions, including Director of the H&B Science Center at CHA Meditech Co., Ltd., Director of the Consumer Health 2 Center at CHA Advanced Research Institute, and Adjunct Associate Professor at CHA University. Her career bridges cutting-edge biomedical research with real-world therapeutic and cosmetic applications, particularly in skin regeneration, aging, and immunology. She has published over 50 scientific papers and filed more than 240 patents, demonstrating innovation and scientific excellence across academia and industry.

Dr Eun-Gyung Cho, CHA R&D Institute/CHABio group, South Korea

Profile

ORCID

SCOPUS

๐ŸŽ“ Education

Dr. Eun-Gyung Cho holds a strong academic foundation in biological sciences and biotechnology. She earned her Ph.D. in Biological Sciences from Seoul National University (1998โ€“2002) ๐Ÿงฌ๐ŸŽ“, where she specialized in molecular and cellular biology. Prior to that, she completed her M.S. in Life Science at GIST, Kwangju (1996โ€“1998) ๐Ÿ”ฌ๐Ÿ“˜, gaining expertise in bio-research and developmental biology. Her academic journey began with a B.S. in Agricultural Biology at Seoul National University (1992โ€“1996) ๐ŸŒฑ๐Ÿงช, where she built her initial skills in genetics, plant science, and biotechnology. This educational pathway laid the groundwork for her exceptional career in biomedical innovation.

๐Ÿข Professional Experience

Dr. Eun-Gyung Cho brings over two decades of dynamic experience across academia, research, and biotechnology innovation. She currently serves as Director at CHA Meditech and the CHA Advanced Research Institute, and is an Adjunct Associate Professor at CHA University ๐Ÿข๐Ÿ”ฌ๐Ÿ“š. Previously, she held senior leadership roles at Amorepacific Corporation, including Team Leader and Chief Scientist, where she led R&D in bio-cosmeceuticals and exosome-based technologies ๐Ÿ’„๐Ÿงซ. Her global expertise is further enriched by postdoctoral research at the NIH and Sanford-Burnham Institute in the USA ๐ŸŒ๐Ÿง . Dr. Cho’s career reflects a blend of scientific depth, leadership, and innovation ๐Ÿ’ก๐Ÿงช.

๐Ÿง–โ€โ™€๏ธ Research Experience

Dr. Eun-Gyung Cho has led a distinguished research career in extracellular vesicles (EVs), stem cell biology, and skin science across academia and industry. At CHA Meditech and Amorepacific, she developed innovative biomaterials including EV-based skin boosters, anti-aging formulations, and microbial-derived therapies ๐Ÿงช๐Ÿง–โ€โ™€๏ธ๐ŸŒฟ. Her postdoctoral work at Sanford-Burnham and NIH advanced neurogenesis, cell cycle regulation, and bio-signaling mechanisms ๐Ÿง ๐Ÿ”ฌ๐Ÿงซ. With over 240 patents and 40+ publications, she has made pioneering contributions in cosmeceuticals, dermaceuticals, and regenerative medicine ๐ŸŒŸ๐Ÿ“ˆ๐Ÿ’Š. Her research bridges fundamental science with real-world applications in skin health and personalized biotherapy.

๐Ÿ”ฌ Research Focus

Dr. Eun-Gyung Choโ€™s research centers on extracellular vesicles (EVs) ๐Ÿงซ, particularly their roles in intercellular communication, drug delivery, and as biomaterials for dermatological therapy ๐Ÿ’‰๐Ÿงด. She specializes in developing skin boosters and biostimulators using EVs, peptides, recombinant proteins, and stem cell-conditioned media ๐Ÿงฌ. Her work extends to skin biology ๐Ÿง–โ€โ™€๏ธโ€”exploring melanogenesis, skin barrier function, and cutaneous immunityโ€”and stem cell biology, including iPSC differentiation into skin and neural lineages ๐ŸŒฑ๐Ÿง . With deep roots in molecular biology, she also investigates cell cycle regulation, tumorigenesis, and apoptosis, bridging fundamental science with regenerative and aesthetic medicine ๐Ÿงช๐Ÿ’ก.

๐Ÿ“š Publications

Human Probiotic Lactobacillus paracasei-Derived Extracellular Vesicles Improve Tumor Necrosis Factor-ฮฑ-Induced Inflammatory Phenotypes in Human Skin
Authors: Kwang-soo Lee, Yunsik Kim, Jin Hee Lee, Suji Shon, Aram Kim, An Vuong Quynh Pham, Chungho Kim, Dong Hyun Kim, Yoon-Keun Kim, Eun-Gyung Cho
Journal: Cells, 2023

Comparative Lipidomic Analysis of Extracellular Vesicles Derived from Lactobacillus plantarum APsulloc 331261 Living in Green Tea Leaves Using Liquid Chromatography-Mass Spectrometry
Authors: Hyoseon Kim, Minjung Kim, Kilsun Myoung, Wanil Kim, Jaeyoung Ko, Kwang Pyo Kim, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2020

Kojyl Cinnamate Ester Derivatives Increase Adiponectin Expression and Stimulate Adiponectin-Induced Hair Growth Factors in Human Dermal Papilla Cells
Authors: Phil June Park, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2019

Circadian Expression of TIMP3 Is Disrupted by UVB Irradiation and Recovered by Green Tea Extracts
Authors: Sunyoung Park, Eun-Soo Lee, Nok-Hyun Park, Kyeonghwan Hwang, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2019

Prof. Dr Yuan Xu | Biomaterials | Best Researcher Award

Published on by Material Scientist

Prof. Dr Yuan Xu | Biomaterials | Best Researcher Award

Prof. Dr. Yuan Xu is a renowned physician-scientist and Chief Physician at the China-Japan Friendship Hospital ๐Ÿฅ. Holding both an MD and PhD, he specializes in the integration of Traditional Chinese Medicine (TCM) and Western medicine ๐Ÿ”ฌ๐ŸŒฑ. He serves as Deputy Director of the National Center for Integrated Medicine and is a Masterโ€™s Supervisor guiding future clinicians ๐ŸŽ“๐Ÿง‘โ€โš•๏ธ. As a former visiting scholar at Yale University, his global outlook informs research on rheumatology, fibromyalgia, and chronic disease care ๐ŸŒ๐Ÿ’ก. With 48 publications, 12 SCI papers, and multiple funded projects, he is a leader in translational healthcare innovation ๐Ÿง ๐Ÿ†.

Prof. Dr Yuan Xu, China-Japan Friendship Hospital, China

Profile

SCOPUS

Education ๐ŸŽ“

Prof. Dr. Yuan Xu holds both an MD and a PhD, establishing a strong foundation in clinical medicine and biomedical research ๐Ÿฉบ๐Ÿ”ฌ. His dual training bridges Western medical science and Traditional Chinese Medicine (TCM), enabling an integrative approach to healthcare ๐ŸŒ๐ŸŒฑ. He further enriched his academic profile as a visiting scholar at Yale University, USA, where he engaged in global research collaboration and advanced clinical studies ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ“–. This diverse educational background equips him with a comprehensive and holistic view of medicine, fueling his innovative work in rheumatology and chronic disease treatment ๐Ÿ’ก๐Ÿง .

Experience ๐Ÿฅ

Prof. Dr. Yuan Xu is a seasoned Chief Physician at the China-Japan Friendship Hospital and serves as a Masterโ€™s Supervisor, nurturing the next generation of clinicians and researchers ๐ŸŽ“๐Ÿ‘จโ€๐Ÿซ. As Deputy Director at the National Center for Integrated Traditional Chinese and Western Medicine, he leads national initiatives merging TCM with modern medical science โš•๏ธ๐ŸŒฟ. Recognized as an Innovative Young Talent and a โ€œNew 125โ€ TCM Leader, he also gained international exposure as a visiting scholar at Yale University ๐ŸŒ๐Ÿ“š. His career spans clinical care, policy leadership, and translational research in chronic disease management ๐Ÿง ๐Ÿฆด.

Contributions ๐Ÿ“–

Prof. Dr. Yuan Xu has made impactful contributions in three core research areas: the development of diagnostic and treatment protocols for rheumatoid arthritis using Traditional Chinese Medicine (TCM) ๐ŸŒฟ๐Ÿฆด, the advancement of fibromyalgia care strategies ๐Ÿง ๐Ÿ’Š, and the management of integrated TCM and Western medical systems ๐Ÿฅโš–๏ธ. He has led 12 major research projects, securing over 10 million yuan in funding ๐Ÿ’ฐ๐Ÿ“Š. His academic output includes 48 publications, with 12 SCI-indexed papers, where he served as first or corresponding author โœ๏ธ๐Ÿ”. His work bridges clinical care and scientific discovery in modern integrative medicine ๐Ÿงฌ๐Ÿฉบ.

Research Focus ๐Ÿ”ฌ

Prof. Dr. Yuan Xuโ€™s research primarily targets rheumatoid diseases, with a strong emphasis on rheumatoid arthritis and fibromyalgia syndrome ๐Ÿฆด๐Ÿงฌ. His work integrates Traditional Chinese Medicine (TCM) and modern biomedical approaches to develop more effective diagnostic models and personalized treatments ๐ŸŒฑโš•๏ธ. He investigates immune system dysregulation, inflammatory pathways, and syndrome differentiation in chronic joint disorders ๐Ÿ”๐Ÿ’Š. Through national and international collaborations, including with Yale University, he bridges ancient practices with advanced clinical research ๐Ÿฅ๐ŸŒ. His translational focus ensures that findings directly improve patient outcomes in chronic rheumatologic care ๐Ÿ“ˆ๐Ÿง‘โ€โš•๏ธ.

Publications ๐Ÿ“š

Early prediction of bone destruction in rheumatoid arthritis through machine learning analysis of plasma metabolites
Authors: Wang Zihan, Lan Tianyi, Jiao Yi, Tao Qingwen, Xu Yuan
Journal: Arthritis Research and Therapy, 2025 ๐Ÿง ๐Ÿ’‰๐Ÿ“Š

Clinical Characteristics and Influencing Factors of Rheumatoid Arthritis in Patients with Cold Dampness Obstruction Syndrome
Authors: Chen Yanyu, Li Yanqi, Liu Longxiao, Xu Yuan, Tao Qingwen
Journal: Chinese Journal of Experimental Traditional Medical Formulae, 2025 ๐ŸŒฟ๐Ÿฆด๐Ÿ“˜

Integrated phytochemistry and network pharmacology analysis to reveal effective substances and mechanisms of Bushen Quhan Zhiwang decoction in the treatment of rheumatoid arthritis
Authors: Zhang Liubo, Yan Yu, Ma Ru, Tao Qingwen, Xu Yuan
Journal: Journal of Ethnopharmacology, 2024 ๐ŸŒฑโš—๏ธ๐Ÿ”Ž

Prof. Dr Ramasamy Paulmurugan | Biomaterials | Best Researcher Award

Published on by Material Scientist

Prof. Dr Ramasamy Paulmurugan | Biomaterials | Best Researcher Award

Prof. Dr. Ramasamy Paulmurugan is a globally recognized biomedical scientist and Professor of Radiology at Stanford University School of Medicine ๐Ÿ›๏ธ. With expertise in molecular imaging, nanomedicine, and gene therapy, his work focuses on cancer diagnostics and targeted therapeutics ๐ŸŽฏ๐Ÿงซ. He leads the Cellular Pathway Imaging Laboratory, developing cutting-edge biosensors and nanoparticle-based delivery systems ๐Ÿ’ก๐Ÿงช. Author of 145+ publications, he has received prestigious awards for innovation and research excellence ๐Ÿ…๐Ÿ“š. His interdisciplinary impact spans academia, clinical research, and biotechnology, making him a trailblazer in translational medicine and precision oncology ๐ŸŒโš•๏ธ.

Prof. Dr Ramasamy Paulmurugan, Stanford University, United States

Profile

SCOPUS

ORCID

GOOGLESCHOLAR

Education ย ๐ŸŽ“

Prof. Dr. Ramasamy Paulmurugan began his academic journey with a B.Sc. in Zoology, Botany, and Chemistry (1986โ€“1989) from Madurai Kamaraj University, India ๐Ÿธ๐ŸŒฟ๐Ÿงช. He pursued an M.Sc. in Biomedical Genetics (1989โ€“1991) at the University of Madras, developing a strong foundation in genetic science and human biology ๐Ÿงฌ๐Ÿง . He then earned a Ph.D. in Biomedical Genetics with specialization in Molecular Virology (1991โ€“1997) from National Environmental Engineering Research Institute and University of Madras, India ๐Ÿ”ฌ๐Ÿฆ . His education equipped him with the interdisciplinary knowledge and research skills essential for his impactful work in cancer biology and molecular medicine ๐Ÿ’กโš•๏ธ.

Honors & Awards ๐Ÿ…

Prof. Dr. Ramasamy Paulmurugan has received numerous prestigious awards throughout his career for outstanding contributions to biomedical science ๐Ÿงฌ๐Ÿง . His accolades include the Best Research Fellow Award (1991) from CSIR-NEERI ๐Ÿ‡ฎ๐Ÿ‡ณ, the Young Scientist Award (1999) from the Government of Kerala, and multiple Travel Awards from international imaging societies for best paper presentations in the USA and Germany โœˆ๏ธ๐Ÿ“„. He was honored with the Distinguished Investigator Award (2018) by the Academy for Radiology & Biomedical Imaging Research ๐Ÿงช and recently received the SAASCR Outstanding Achievement Award (2025) for advancing Asian American cancer research ๐ŸŒ๐Ÿ”ฌ.

Experience ย ๐Ÿฅ

Prof. Dr. Ramasamy Paulmurugan has over three decades of research and academic experience across India and the United States ๐ŸŒ. He began as a Junior and Senior Research Fellow in Molecular Virology in India (1991โ€“1996) ๐Ÿ”ฌ, later leading the Environmental Biotechnology Division at RGCB as Scientist B and C (1996โ€“1999, 1999โ€“2003) ๐Ÿงซ. He was a Visiting Scientist at UCLA (2001โ€“2003) ๐Ÿง , then joined Stanford University, where he advanced from Senior Research Scientist to Professor of Radiology (2003โ€“present) ๐Ÿ›๏ธ. His roles have spanned molecular imaging, translational research, and biomedical innovation across prestigious global institutions ๐Ÿ’ก๐Ÿ“ˆ.

Book Chapter ๐Ÿ“–

Prof. Dr. Ramasamy Paulmurugan has authored and co-authored over 27 book chapters, contributing to prestigious scientific volumes on molecular imaging, cancer biology, gene therapy, bioluminescence, and nanomedicine ๐Ÿ“–๐Ÿ”ฌ. His work spans publishers like Springer, Elsevier, Cambridge University Press, and World Scientific, reflecting his expertise in cutting-edge biomedical innovations ๐ŸŒ๐Ÿ“—. Topics include theranostics, glioblastoma resistance, protein-protein interaction imaging, microRNA therapy, and nanoparticle-based delivery systems for precision medicine ๐ŸŽฏ๐Ÿ’Š. His chapters are widely cited and used globally in advanced medical research, showcasing his status as a thought leader in translational and molecular medicine ๐Ÿงช๐ŸŒŸ.

Conference Presentations ๐ŸŒ๐ŸŽค

Prof. Dr. Ramasamy Paulmurugan has presented over 220 abstracts at leading international conferences spanning oncology, molecular imaging, nanomedicine, and gene therapy ๐Ÿงฌ๐Ÿง . His research has been showcased at AACR, WMIC, RSNA, IEEE, ASNR, and SPIE, reflecting sustained excellence and innovation across decades ๐Ÿ›๏ธ๐Ÿ”ฌ. Topics include molecular biosensors, microRNA therapy, nanoparticle delivery, ultrasound imaging, and cancer diagnostics. These presentations highlight collaborations with global experts and his role in pioneering translational research that bridges bench to bedside ๐Ÿงชโžก๏ธ๐Ÿฅ. His prolific and consistent contributions demonstrate global recognition and influence in biomedical innovation ๐ŸŒ๐Ÿ….

Research Focus ๐Ÿ”ฌ

Prof. Dr. Ramasamy Paulmuruganโ€™s research centers on molecular imaging, nanomedicine, and gene-based therapies to combat cancer and metabolic diseases like diabetes ๐Ÿง โš•๏ธ. He pioneers in vivo imaging of proteinโ€“protein interactions, miRNA delivery, and biosensor technologies for real-time monitoring of disease pathways ๐Ÿงฌ๐Ÿ“ธ. His innovations include split-luciferase systems, cell membrane-coated nanocarriers, and redox-sensitive signaling tools for precision therapeutics ๐ŸŽฏ๐Ÿงช. Bridging molecular biology with biomedical engineering, his translational research focuses on targeted drug delivery, noninvasive diagnostics, and theranostic nanoparticles, contributing significantly to personalized medicine and cancer theranostics ๐Ÿ’‰๐Ÿง ๐ŸŒ.

Publications ๐Ÿ“š

The fate and toxicity of Raman-active silica-gold nanoparticles in mice
Authors: A.S. Thakor, R. Luong, R. Paulmurugan, F.I. Lin, P. Kempen, C. Zavaleta, et al.
Journal: Science Translational Medicine, Vol. 3 (79), 79ra33

Noninvasive quantitative imaging of proteinโ€“protein interactions in living subjects
Authors: P. Ray, H. Pimenta, R. Paulmurugan, F. Berger, M.E. Phelps, M. Iyer, et al.
Journal: Proceedings of the National Academy of Sciences (PNAS), Vol. 99 (5), 3105โ€“3110

The emerging role of redox-sensitive Nrf2โ€“Keap1 pathway in diabetes
Authors: E. Bhakkiyalakshmi, D. Sireesh, P. Rajaguru, R. Paulmurugan, et al.
Journal: Pharmacological Research, Vol. 91, 104โ€“114

Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer
Authors: T.Y. Wang, J.W. Choe, K. Pu, R. Devulapally, S. Bachawal, S. Machtaler, R. Paulmurugan, et al.
Journal: Journal of Controlled Release, Vol. 203, 99โ€“108

Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging
Authors: M. Krishnan, J.M. Park, F. Cao, D. Wang, R. Paulmurugan, J.R. Tseng, et al.
Journal: FASEB Journal, Vol. 20 (1), 106โ€“108

Firefly luciferase enzyme fragment complementation for imaging in cells and living animals
Authors: R. Paulmurugan, S.S. Gambhir
Journal: Analytical Chemistry, Vol. 77 (5), 1295โ€“1302

Molecular imaging of drug-modulated protein-protein interactions in living subjects
Authors: R. Paulmurugan, T.F. Massoud, J. Huang, S.S. Gambhir
Journal: Cancer Research, Vol. 64 (6), 2113โ€“2119

Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction
Authors: N. Jothikumar, K. Aparna, S. Kamatchiammal, R. Paulmurugan, et al.
Journal: Applied and Environmental Microbiology, Vol. 59 (8), 2558โ€“2562

Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system
Authors: R. Paulmurugan, S.S. Gambhir
Journal: Analytical Chemistry, Vol. 79 (6), 2346โ€“2353

Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics
Authors: R.J.C. Bose, R. Paulmurugan, J. Moon, S.H. Lee, H. Park
Journal: Drug Discovery Today, Vol. 23 (4), 891โ€“899